They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...

Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...

Shares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales ...

Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV vaccine there is expected to hurt 2025 revenue, but it still posted a strong ...

Cervical cancer continues to be one of the leading causes of cancer-related deaths among women, and the Caribbean region has ...

The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at ...

(Reuters) -Merck said on Tuesday it would not ship its HPV vaccine Gardasil in China until ... compared with analyst forecasts of around $7.4 billion.

Gardasil is a vaccine that prevents cancer from HPV ... cats and cattle, posted nearly $1.4 billion in sales, up 9% from the same period a year ago. The company said higher pricing for products ...

Merck MRK-N said on Tuesday it would not ship its HPV vaccine Gardasil in China until ... compared with analyst forecasts of around $7.4 billion. Total revenue rose to $15.6 billion from $14.6 ...